CDC Announces $22 Billion to Support Expanded COVID-19 Testing and Vaccine Distribution

This week, the U.S. Centers for Disease Control and Prevention (CDC) announced two upcoming actions to provide more than $22 billion in funding to states, localities, and territories to support the continued response to the ongoing COVID-19 pandemic. The funding was made available through the Coronavirus Response and Relief Supplemental Appropriations Act that was passed by Congress and signed into law late last month.

Funding will provide support for testing and vaccination-related activities to jurisdictions before January 19, 2021. Award recipients will include 64 jurisdictions, including all 50 states, the District of Columbia, five major cities, and U.S. territories/islands.

More than $19 billion will be allocated though the existing CDC Epidemiology and Laboratory Capacity (ELC) cooperative agreement. These funds will support testing, contact tracing, surveillance, containment, and mitigation activities. Over $3 billion will also be made available in an initial award to jurisdictions through the existing CDC Immunization and Vaccines for Children cooperative agreement. These awards will support a range of COVID-19 vaccine activities throughout the country.

Additional information on the new funding is available here.